Inventor · disambiguated record
Oliver Daumke
Also filed as: DAUMKE OLIVER
6 granted patents·18 citations·filing 2013–2020
77Inventor score
Files withMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT4MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN1Max-Delbrück-Centrum für Molekulare Medizin 1
Top patents by PatentIndex Score
6 records- 0187US10144782B2Humanized antibodies against CD269 (BCMA)MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2015·Granted Dec 4, 2018·8 cites·11 claims
- 0282US10189906B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN·Filed 2013·Granted Jan 29, 2019·7 cites·8 claims
- 0379US10745486B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMax-Delbrück-Centrum für Molekulare Medizin ·Filed 2018·Granted Aug 18, 2020·3 cites·9 claims
- 0468US11820829B2Humanized antibodies against CD269 (BCMA)MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2020·Granted Nov 21, 2023·0 cites·19 claims
- 0566US10851172B2Humanized antibodies against CD269 (BCMA)MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2018·Granted Dec 1, 2020·0 cites·17 claims
- 0665US11667722B2Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseasesMAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT·Filed 2020·Granted Jun 6, 2023·0 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →